Skip to Main content Skip to Navigation
Journal articles

Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial function

Abstract : The tumor suppressor BAP1 associates with ASXL1/2 to form the core Polycomb complex PR-DUB, which catalyzes the removal of mono-ubiquitin from several substrates including histone H2A. This complex also mediates the poly-deubiquitination of HCFC1, OGT and PCG1-α, preventing them from proteasomal degradation. Surprisingly, considering its role in a Polycomb complex, no transcriptional signature was consistently found among BAP1-inactivated tumor types. It was hypothesized that BAP1 tumor suppressor activity could reside, at least in part, in stabilizing proteins through its poly-deubiquitinase activity. Quantitative mass spectrometry and gene expression arrays were used to investigate the consequences of BAP1 expression modulation in the NCI-H226 mesothelioma cell line. Analysis of differentially expressed proteins revealed enrichment in cytoskeleton organization, mitochondrial activity and ROS management, while gene expression analysis revealed enrichment in the epithelial-to-mesenchymal transition pathway. Functional assessments in BAP1 inactivated, BAP1 wild-type and BAP1 catalytically dead-expressing NCI-H226 and QR mesothelioma cell lines confirmed alteration of these pathways and demonstrated that BAP1 deubiquitinase activity was mandatory to maintain these phenotypes. Interestingly, monitoring intracellular ROS levels partly restored the morphology and the mitochondrial activity. Finally, the study suggests new tumorigenic and cellular functions of BAP1 and shows for the first time the interest of studying the proteome as readout of BAP1 inactivation.
Complete list of metadatas

Cited literature [41 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02478605
Contributor : Didier Jean <>
Submitted on : Friday, February 14, 2020 - 1:44:25 AM
Last modification on : Tuesday, July 21, 2020 - 3:59:19 AM
Long-term archiving on: : Friday, May 15, 2020 - 12:38:21 PM

File

19872-286186-5-PB.pdf
Publication funded by an institution

Identifiers

Citation

Lucie Hébert, Dorine Bellanger, Chloé Guillas, Antoine Campagne, Florent Dingli, et al.. Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial function. Oncotarget, Impact journals, 2017, 8 (42), pp.72513-72527. ⟨10.18632/oncotarget.19872⟩. ⟨inserm-02478605⟩

Share

Metrics

Record views

349

Files downloads

720